Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy

American Journal of Health-System Pharmacy

Volumn 66, Issue 16, 2009, Pages 1471-1477

  Benner, Joshua S ^a,b   Chapman, Richard H ^c   Petrilla, Allison A ^c   Tang, Simon S K ^d   Rosenberg, Noah ^e   Schwartz, J Sanford ^f  

^a BROOKINGS INSTITUTION   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c IQVIA   (United States)

^d PFIZER INC   (United States)

^e SANOFI   (France)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antilipemic agents; Compliance; Hyperlipidemia; Hypertension; Hypotensive agents; Managed care systems; Patients

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; ASSOCIATION; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PRESCRIPTION; PRESCRIPTION BURDEN; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

EID: 69249190363     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080238     Document Type: Article

References (41)

1. 4S Investigators. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344:1383-1389
2. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-1307
3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339:1349-1357
4. Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366:1267-1278
5. Turnbull F, Neal B, Algert C et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005; 165:1410-1419 (Pubitemid 40973424)
6. Avorn J, Monette J, Lacour A et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998; 279:1458-1462 (Pubitemid 28228203)
7. Benner JS, Glynn RJ, Mogun H et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002; 288:455-461 (Pubitemid 34787476)
8. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002; 288:462-467 (Pubitemid 34787477)
9. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002; 36:1532-1539
10. Blackburn DF, Dobson RT, Blackburn JL et al. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy. 2005; 25:1035-1043
11. Kulkarni SP, Alexander KP, Lytle B et al. Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006; 151:185-191 (Pubitemid 41815352)
12. Ho PM, Rumsfeld JS, Masoudi FA et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166:1836-1841 (Pubitemid 44455165)
13. Sokol MC, McGuigan KA, Verbrugge RR et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005; 43:521-530
14. Ho PM, Spertus JA, Masoudi FA et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006; 166:1842-1847
15. Masoudi FA, Baillie CA, Wang Y et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005; 165:2069-2076
16. Chapman RH, Petrilla AA, Benner JS et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging. 2008; 25:885-892
17. Chapman RH, Benner JS, Petrilla AA et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165:1147-1152
18. Grant RW, O'Leary KM, Weilburg JB et al. Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med. 2004; 164:2343-2348
19. Grant RW, Singer DE, Meigs JB. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005; 27:773-781
20. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J. 2002; 95:68-71. (Pubitemid 34131538)
21. Cramer JA, Roy A, Burrell A et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008; 11:44-47
22. Ho PM, Magid DJ, Shetterly SM et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008; 168:271-6.
23. Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health-Syst Pharm. 2007; 64:1279-1283 (Pubitemid 47216196)
24. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50:105-116
25. McGinnis B, Olson KL, Magid D et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007; 41:1805-1811
26. Eagle KA, Kline-Rogers E, Goodman SG et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004; 117:73-81. (Pubitemid 38953725)
27. Blackburn DF, Dobson RT, Blackburn JL et al. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol. 2005; 21:485-488
28. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000; 9:2-6.
29. Legorreta A, Yu A, Chernicoff H et al. Adherence to combined lamivudine + zidovudine versus individual components: a community-based retrospective Medicaid claims analysis. AIDS Care. 2005; 17:938-948 (Pubitemid 41499307)
30. Su WJ, Perng RP. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. Int J Tuberc Lung Dis. 2002; 6:1029-1032
31. Vanderpoel DR, Hussein MA, Watson-Heidari T et al. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clin Ther. 2004; 26:2066-2075
32. Melikian C, White TJ, Vanderplas A et al. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002; 24:460-467 (Pubitemid 34275867)
33. Bangalore S, Kamalakkannan G, Parkar S et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007; 120:713-719 (Pubitemid 47176510)
34. Asplund J, Danielson M, Ohman P. Patients compliance in hypertension-the importance of number of tablets. Br J Clin Pharmacol. 1984; 17:547-552 (Pubitemid 14057461)
35. Merikle EP, Evans C, Feldman RD. Patient satisfaction with a single-pill treatment of hypertension and dyslipidemia. Circulation. 2007; 115:e589. Abstract.
36. Bouchard MH, Dragomir A, Blais L et al. Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol. 2007; 63:698-708. (Pubitemid 46753568)
37. Cherry SB, Benner JS, Hussein MA et al. The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Value Health. 2009; 12:489-497
38. Bramley TJ, Gerbino PP, Nightengale BS et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006; 12:239-245
39. Mason CM. The nurse practitioner's role in helping patients achieve lipid goals with statin therapy. J Am Acad Nurse Pract. 2005; 17:256-262
40. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006; 296:2563-2571
41. Schroeder K, Fahey T, Hollinghurst S et al. Nurse-led adherence support in hypertension: a randomized controlled trial. Fam Pract. 2005; 22:144-151 (Pubitemid 40533088)